| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5824520 | Clinical Therapeutics | 2015 | 13 Pages |
Abstract
The aggressive management of contributing factors, including hypertension, atrial fibrillation, and myocardial ischemia, is key in the management of HFPEF. New insights into the mechanisms and thus the identification of potential therapeutic strategies are urgently required.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Shane MBBS, David M. MBBS, PhD,